Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DapaTAVI
NCT04696185Phase 4Completed
- Sponsor
- Sociedad Española de Cardiología
- Start
- Jan 2021
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dapagliflozin in heart failure (HF), sponsored by Sociedad Española de Cardiología. Started Jan 2021; status: completed.
02
Drugs
dapagliflozin
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT04696185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04696185.